Tag Archives: John Zajecka

H. Lundbeck A/S, Takeda announced that US FDA accepted a supplemental New Drug Application (sNDA) for review of Brintellix (vortioxetine)

Posted on 12, August 2015 by

Valby, Denmark and Osaka, Japan, 12-8-2015 — /EuropaWire/ — H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) announced today the US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for review to add … Read the full press release →

Posted in Denmark, Government, Healthcare, Pharma & Biotech

Tagged , , , , , , , ,